Submitted by Anonymous (not verified) on 13 May 2024 - 15:04
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 10, Status: Authorised
Source: